SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-15-003416
Filing Date
2015-05-06
Accepted
2015-05-06 16:01:01
Documents
11
Period of Report
2015-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q ceru-10q_20150331.htm 10-Q 1301049
2 EX-31.1 ceru-ex311_2015033112.htm EX-31.1 11694
3 EX-31.2 ceru-ex312_2015033113.htm EX-31.2 11691
4 EX-32.1 ceru-ex321_2015033114.htm EX-32.1 4451
5 EX-32.2 ceru-ex322_2015033115.htm EX-32.2 4461
  Complete submission text file 0001564590-15-003416.txt   4841834

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT ceru-20150331.xml EX-101.INS 592372
7 XBRL TAXONOMY EXTENSION SCHEMA ceru-20150331.xsd EX-101.SCH 29647
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ceru-20150331_cal.xml EX-101.CAL 28334
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ceru-20150331_def.xml EX-101.DEF 98098
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE ceru-20150331_lab.xml EX-101.LAB 258001
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ceru-20150331_pre.xml EX-101.PRE 192391
Mailing Address 840 MEMORIAL DRIVE 5TH FLOOR Cambridge MA 02139
Business Address 840 MEMORIAL DRIVE 5TH FLOOR Cambridge MA 02139 617-551-9600
Cerulean Pharma Inc. (Filer) CIK: 0001401914 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36395 | Film No.: 15836865
SIC: 2834 Pharmaceutical Preparations